The Apex Times
Above the Noise
Business Wire
BusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex Times
Back to front
Johnson & Johnson declares $1.34 quarterly dividend for third quarter 2026
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jul 15, 6:39 AM EDT

Johnson & Johnson declares $1.34 quarterly dividend for third quarter 2026

The New Brunswick, New Jersey-based healthcare company’s board set the cash dividend at $1.34 per common share for the July-to-September quarter, a routine shareholder payout that outlines continued capital return.

By The Apex Times Newsroom2 min readAI-assisted Apex article

Johnson & Johnson said its Board of Directors has declared a cash dividend for the third quarter of 2026 of $1.34 per share on the company’s common stock. The declaration was announced on July 15, 2026.

In the release distributed via market coverage, the company did not provide additional dividend mechanics such as the payment date, or the applicable record date, at least not in the text that was circulated. That means investors looking for when shares must be held to receive the dividend would need to consult the full company filing or subsequent investor communications, if issued.

A quarterly dividend is a cash payment companies make to common shareholders, typically at regular intervals. For mature large-cap companies such as Johnson & Johnson, these payouts are often used as a straightforward way to return a portion of earnings and free cash flow to shareholders, alongside any share repurchases.

The declared rate of $1.34 per share applies specifically to the third quarter of 2026, covering Johnson & Johnson’s fiscal quarter that runs through the months ending in September. Because the announcement is framed around the quarter, the company is treating the payment as part of its ongoing distribution schedule rather than a one-off adjustment.

While the declaration itself is limited in detail, the action falls within a broader pattern in global healthcare, where large diversified drug and medical device companies balance investment in pipelines and manufacturing with shareholder distributions. Even when companies face industry pressures such as pricing scrutiny or patent-driven revenue shifts, dividends can be an important element of capital allocation messaging.

Johnson & Johnson’s portfolio spans pharmaceuticals and medical technology, and dividends are commonly viewed in such business models as a stabilizing announcement during periods of operational variability. In the context of this announcement, the company’s choice to declare a third-quarter dividend at the stated per-share level underscores that it intends to continue routine cash returns during 2026.

The company announcement, as reflected in the market coverage, did not disclose any rationale for the specific quarterly amount, nor did it describe whether this dividend reflects changes in earnings, cash generation, or payout policy. It also did not mention any linkage to upcoming product launches, regulatory events, or financial guidance in the text circulated.

Why It Matters

  • A declared quarterly dividend provides a near-term, concrete form of capital return to common shareholders.
  • Routine dividend declarations can help investors gauge management’s confidence in recurring cash generation, even when operating conditions are uncertain.
  • Missing payment and record-date information in the circulated text means investors may need to look for follow-up details before acting.
  • The dividend amount can influence how income-focused investors view the stock going into the third quarter.

Sources

Key Facts

  • Johnson & Johnson declared a cash dividend of $1.34 per share for the third quarter of 2026.
  • The dividend applies to the company’s common stock.
  • The announcement was made on July 15, 2026.
  • The market coverage did not include payment date or record date details in the circulated text.
  • The declaration was made by Johnson & Johnson’s Board of Directors.

Healthcare Related

Johnson & Johnson declares $1.34 quarterly dividend for third quarter 2026 | The Apex Times